News GSK plc

Equities

GSK

GB00BN7SWP63

Pharmaceuticals

Real-time Estimate Cboe Europe Other stock markets 04:34:13 2026-04-16 am EDT			5-day change	1st Jan Change
2,122.00 ^GBX	-0.42%		-1.98%	+16.42%

Apr. 15	London's FTSE 100 ends lower as healthcare weighs; Mideast in focus	RE
Apr. 15	Adimab collaborator GSK receives additional marketing approval for depemokimab	RE

All News

Apr. 15	London's FTSE 100 ends lower as healthcare weighs; Mideast in focus	RE
Apr. 15	Adimab collaborator GSK receives additional marketing approval for depemokimab	RE
Apr. 15	European Stocks Track Mostly Lower in Wednesday Trading	MT
Apr. 15	Traders weigh war deadlock; luxury woes hit Paris	AN
Apr. 15	Wall Street: Still Cautious, Still Buying
Apr. 15	GSK Completes $950 Million Acquisition of 35Pharma to Boost Pulmonary Hypertension Pipeline	MT
Apr. 15	GSK plc completed the acquisition of 35Pharma Inc.	CI
Apr. 15	GSK completes purchase of Canada's 35Pharma for USD950 million	AN
Apr. 15	GSK Concludes $950 Million Acquisition of Canada's 35Pharma	MT
Apr. 15	"Double Down", Come What May
Apr. 14	Betting on Restraint
Apr. 14	Pharma sector doubles down on AI amid hopes of slashing costs, timelines	RE
Apr. 14	GSK : Gets a Neutral rating from Deutsche Bank	ZD
Apr. 14	GSK : Barclays remains a Sell rating	ZD
Apr. 14	The V for victory, at least on the charts
Apr. 13	LIXTE Biotechnology Holdings, Inc. Presents Favorable Results For LB-100 And Dostarlimab Combination In Ovarian Cancer Study	CI
Apr. 13	European Stocks Fall in Monday Trading After US-Iran Peace Talks Collapse	MT
Apr. 13	Earnings Season in Trump's Shadow
Apr. 13	NRx Pharmaceuticals, Inc. Announces Appointment of Glenn Tyson as Chief Commercial Officer	CI
Apr. 13	Bioversys Ag Publishes Pre-Clinical Data of Alpe Drug Combination in Nature Communications	CI
Apr. 13	GSK : JP Morgan maintains a Sell rating	ZD
Apr. 13	GSK : Jefferies gives a Buy rating	ZD
Apr. 13	GSK Reports Phase I Trial Data for Mocertatug Rezetecan in Gynaecological Cancers	MT
Apr. 13	Bernstein cuts Wizz Air and easyJet	AN
Apr. 13	GSK : Goldman Sachs remains Neutral	ZD